Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 4
Primary Industries
- Drugs
- Disease
- Therapeutic
- Pharmaceuticals
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 253919
The Parent Agreement shall terminate in its entirety as of the Amendment Effective Date.
With this Additional Development License , the Licensor grants a non-exclusive right and license under the Licensor Know-How, Patent Rights and Licensors rights under Joint Patent Rights to Develop and Manufacture VX-950 and Products containing VX-950 in North America.
Compound means VX-950, or any Backup Compound that is included in this Agreement, and all of its or their prodrugs and metabolites, its or their stereoisomers and tautomers, and all of the esters, salts, hydrates, solvates, inclusion complexes and polymorphs of any of the foregoing.
IPSCIO Record ID: 248373
For the Commercialization License, Licensor grants an exclusive right and license under Licensor Patent Rights and Licensors rights under Joint Patent Rights, to Commercialize Product Candidates and Products in the Territory in the Field.
For the Know-How License, Licensor grants an exclusive license in the Field in the Territory under all Licensor Know-How to the extent that it relates exclusively to Compounds, Product Candidates or Products, solely to discharge Licensees obligations and exercise its rights under this Agreement.
For the Manufacturing License, Licensor grants an exclusive license in the Field in the Territory to Manufacture Product Candidates and Products for Commercial use in the Territory, and a co-exclusive, with Licensor, right and license to Manufacture Product Candidates and Products for purposes of exercising its rights under the Development License, in each case under Licensor Patent Rights, Licensor Know-How and Licensors right under Joint Patent Rights.
For the License of Trademarks, prior to Commercialization of a Product, the Parties shall enter into a trademark licensing agreement to use logos chosen and owned by Licensor and the Trademarks Controlled by Licensor, on labeling, package inserts, monographs and packaging materials for the Product, Product Materials and samples, and other materials used in connection with the performance of this Agreement during its term.
Compound means VX-950, or any Backup Compound that is included in this Agreement, and all of its or their prodrugs and metabolites, its or their stereoisomers and tautomers, and all of the esters, salts, hydrates, solvates, inclusion complexes and polymorphs of any of the foregoing.
Product means any pharmaceutical preparation in final commercial form containing the Product Candidate, for sale by prescription, over-the-counter or any other method. Product includes without limitation any Combination Product.
Product Candidate means a pharmaceutical composition containing a Compound as an active ingredient.
The property includes US patent application 10/344,112 and related applications.
VX-950 is an investigational oral inhibitor of hepatitis C virus protease, an enzyme essential for viral replication, and is one of the most advanced investigational agents that specifically targets HCV. In clinical studies to date, researchers have observed rapid and dramatic antiviral activity with VX-950.
IPSCIO Record ID: 2795
IPSCIO Record ID: 233451
The initial compound means the compound ICA-17043 having the molecular structure set forth and any hydrates, anhydrides, solvates, salts, esters, isomers, prodrugs, metabolites or polymorphs thereof.
The Product means a pharmaceutical product that contains, incorporates or is comprised of the Compound, whether in development or approved by any Regulatory Authority, including all formulations, line extensions and modes of administration thereof.
The Licensor Patents means all Patents, other than CMCC Patents, Controlled by Licensor as of the Effective Date or during the Term, that, absent rights thereunder, would be infringed by the Development, Manufacture, formulation, use, distribution, importation, sale, or offer for sale of Compound or Product, including without limitation any such Patents claiming the composition of matter or the use of Compound or Product or any Improvements thereto.
Licensors know-how means all Information, except for CMCC Know-How, that Licensor Controls as of the Effective Date or during the Term.
